SLP Company Profile and Key Details

Q: Who are the executives of SLP?

Dr. Brett A. Howell Ph.D.Pres of DILIsym Services, IncMr. Shawn M. O'ConnorChief Executive OfficerDr. Bud Nelson J.D., Ph.D.Vice President of Corporation Counsel & Personal Data Protection OfficerMr. William FrederickChief Financial Officer & Sec.Mr. Walter S. Woltosz M.A.S., M.S.Co-Founder & ChairmanMs. Jill Fiedler-Kelly M.S., MSPres of Cognigen DivisionMs. Viera Lukacova Ph.D.Chief Science OfficerMs. Arlene PadronCorporation Director of MarketingMs. Lindsay LukeExecutive Director of HRMr. John Anthony DiBella M.S.Pres

NASDAQ : SLP

Simulations Plus

$20.44

0.175+0.86%

Open: 3:28 PM

80.82

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Simulations Plus, Inc. (SLP) stock surged +0.86%, trading at $20.44 on NASDAQ, up from the previous close of $20.26. The stock opened at $20.40, fluctuating between $20.16 and $20.72 in the recent session.

Stock Snapshot

20.26

Prev. Close

411.7M

Market Cap

20.16

Day Low

-6.39

P/E Ratio

-3.2

EPS (TTM)

0.64

Cash Flow per Share

20.4

Open

20.15M

Number of Shares

20.72

Day High

82.57%

Free Float in %

8.86

Book Value

193.66K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jan 20, 2026	19.92	20.45	19.50	20.26	245.65K
Jan 16, 2026	20.27	20.54	20.05	20.33	262.83K
Jan 15, 2026	19.89	20.60	19.48	20.26	293.84K
Jan 14, 2026	19.73	20.00	19.30	19.89	336.77K
Jan 13, 2026	18.92	20.07	18.77	19.87	444.19K
Jan 12, 2026	19.07	19.58	18.29	18.91	534.98K
Jan 09, 2026	16.87	19.64	16.00	19.60	913.78K
Jan 08, 2026	18.70	19.02	17.84	18.05	527.35K
Jan 07, 2026	19.40	19.67	18.87	18.99	255.31K
Jan 06, 2026	19.20	19.78	18.65	19.27	375.12K
Jan 05, 2026	18.26	19.23	18.21	19.20	264.08K
Jan 02, 2026	18.39	18.64	17.73	18.11	224.37K
Dec 31, 2025	18.19	18.37	18.01	18.23	153.44K
Dec 30, 2025	18.27	18.44	18.10	18.22	163.47K
Dec 29, 2025	18.62	18.81	18.25	18.27	173.81K
Dec 26, 2025	19.19	19.31	18.61	18.76	173.66K
Dec 24, 2025	19.26	19.54	19.07	19.18	121.09K
Dec 23, 2025	19.33	19.62	18.99	19.33	195.05K
Dec 22, 2025	18.89	19.61	18.89	19.34	246.37K
Dec 19, 2025	18.63	18.97	18.48	18.75	326.89K

Contact Details

Lancaster, CA 93534-7059

United States

https://www.simulations-plus.com 661 723 7723

About Company

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

Stock Peers

NUTX

0.99+0.65%

Nutex Health, Inc.$153.76 BTSGU

-1.29-0.98%

BrightSpring Health Services, Inc. Tangible Equity Unit$130.09 WGS

-8.4-7.77%

GeneDx Holdings Corp.$99.68 HQY

-1.37-1.60%

HealthEquity, Inc.$84.00 GEHC

-2.92-3.57%

GE HealthCare Technologies Inc.$78.83 TEM

-3.55-5.05%

Tempus AI, Inc.$66.78 OMCL

-1.46-2.89%

Omnicell, Inc.$49.06 BTSG

-0.47-1.20%

BrightSpring Health Services, Inc. Common Stock$38.73 HTFL

-2.97-7.99%

Heartflow, Inc. Common Stock$34.19 PINC

0.09+0.32%

Premier, Inc.$28.26

Company Overview

Simulations Plus, Inc. (NASDAQ:SLP) closed at $20.43 USD, gaining $0.17 (0.86%) from the previous close of $20.26. The stock is currently mid-range between its 52-week high and low $12.39 and $37.67. With a market capitalization of about $411.70 million, Simulations Plus, Inc. is classified as a small-cap and shows market-like volatility (beta ~1.09). Key stats such as the average daily volume over the past year has been around 384.98 thousand shares, volume is running light vs its 52-week average. Headquartered in Lancaster, CA, Simulations Plus, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Shawn O'Connor, the company employs approximately 243 people and listed since June 18, 1997. Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.

Technical Performance

SLP has shown sold momentum, gaining 7.14% over the past week and 31.56% over the past quarter, though year-to-date performance is up 11.14%. Short-term trend indicators are mixed aligned (SMA20 5.85%, SMA50 9.34%, SMA200 1.91%). The stock’s 14-day RSI is 60.61 (firm momentum), while the ATR of 0.99 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -46.21% below its high and over 63.52% above its low. Average 10-day trading volume of 353.04 thousand shares is in line with the 3-month average of 376.85 thousand, indicating normal recent market interest.

Valuation Metrics

Simulations Plus, Inc. trades at a P/E ratio of -6.36, slightly below the S&P 500 average, with a price-to-sales ratio of 5.19 and a price-to-book ratio of 3.21 trading at moderately above to book value. The P/FCF stands at 17.76, also above market averages.

Dividend & Fair Value

Simulations Plus, Inc. last paid a dividend of 0.24 per share, this equals a trailing yield of roughly 0.58%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $32.99. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

The latest quarter delivered EPS of $0.10. The next quarter is forecast at $0.30. Next year's EPS is expected at $25.25. Analyst sentiment is bullish. Analyst rating data shows there are 3 Strong Buy ratings, 2 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $37.00 to $16.00. The high target offers 82.63% upside. The low target suggests -21.03% downside. The mean target is $25.43. This offers 25.52% upside. Simulations Plus, Inc. earnings surprise history is a mixed track record. The quarter that ended December 01, 2025, missed forecasts by 0.0%. The prior quarter beat by -14.29%. Over the last six quarters, Apple has recorded several small beats. These include -9.09% in October 23, 2024.

Shareholding & Insider Activity

Simulations Plus, Inc. has 20.13 million shares outstanding. The public float is 16.62 million shares, elevated short interest at 13.84% of float. This equals 1.60 million shares. The short ratio is 1.78 days. Institutional investors hold 95.27% of the float. Insiders own 17.26%. WOLTOSZ VIRGINIA E holds 4.10 million shares, WOLTOSZ WALTER S has 3.29 million shares and DiBella John Anthony II has 74.43 thousand shares. Over the past six months, insider transactions show net selling. They sold 22.60 thousand shares across 4 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Simulations Plus generated $79.18M in revenue, or $3.94 per share. Gross margin was 58.38%, operating margin -89.33%, and net profit margin -81.74%. Returns are negative, with ROA at -49.05% and ROE at -51.86%.
On valuation metrics, Simulations Plus trades at a P/E of -6.36, P/S of 5.19 and P/B of 3.21. The current ratio is 5.62 and quick ratio is 5.62. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 46.47 days. Debt-to-equity is 0.00, supported by a cash flow-to-debt ratio of 42.43.

Quarterly Financial Highlights

For the quarter ended Aug 31, 2025, Simulations Plus posted revenue of $79.18M, down slightly from $70.01M in the prior quarter. Gross profit was $46.22M (margin 58.38%). Operating income was - $70.73M (margin -89.3%). Net income was- $64.72M (EPS - $3.22).
The company ended the quarter with $32.35M in cash and short-term investments, a total debt of $616.00K, and net debt of - $30.24M. Total assets were $131.94M, with equity of $124.80M. Financials further reflected stability, with operating cash flow of $18.13M, free cash flow of $17.41M, and capital expenditures of - $713.00K.

Price Forecast & Outlook

Our AI price prediction model suggests that Simulations Plus, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.89%, with price expected at $20.44 by February 03, 2026, within a range of $19.34 to $21.46 3-Month Outlook: Projected rise of 26.8%, reaching $25.69 by April 16, 2026, with a range of $23.97 to $27.05. 1-Year Outlook: Projected loss of -51.43%, with price at $9.84 by January 15, 2027, within a range of $7.20 to $12.31.

Key Takeaways

Simulations Plus, Inc. (NASDAQ:SLP) shares are up 11.14% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Simulations Plus, Inc. trading at a premium to the broader market with a P/E of -6.36. Analyst sentiment is mixed, with the majority of ratings in Hold territory and a mean price target of $46.50, suggesting 129.52% upside. Our AI forecast model points to short-term strength (0.89% over two weeks), a medium-term rise (26.8% over three months), and a longer-term loss (-51.43% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Simulations Plus, Inc. (SLP) stock price?

Simulations Plus, Inc. (NASDAQ: SLP) stock price is $20.44 in the last trading session. During the trading session, SLP stock reached the peak price of $20.72 while $20.16 was the lowest point it dropped to. The percentage change in SLP stock occurred in the recent session was 0.86% while the dollar amount for the price change in SLP stock was $0.18.

SLP's industry and sector of operation?

The NASDAQ listed SLP is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. Simulations Plus, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SLP?

Dr. Brett A. Howell Ph.D.
Pres of DILIsym Services, Inc
Mr. Shawn M. O'Connor
Chief Executive Officer
Dr. Bud Nelson J.D., Ph.D.
Vice President of Corporation Counsel & Personal Data Protection Officer
Mr. William Frederick
Chief Financial Officer & Sec.
Mr. Walter S. Woltosz M.A.S., M.S.
Co-Founder & Chairman
Ms. Jill Fiedler-Kelly M.S., MS
Pres of Cognigen Division
Ms. Viera Lukacova Ph.D.
Chief Science Officer
Ms. Arlene Padron
Corporation Director of Marketing
Ms. Lindsay Luke
Executive Director of HR
Mr. John Anthony DiBella M.S.
Pres

How SLP did perform over past 52-week?

SLP's closing price is 63.52% higher than its 52-week low of $12.39 where as its distance from 52-week high of $37.67 is -46.22%.

How many employees does SLP have?

Number of SLP employees currently stands at 243.

Link for SLP official website?

Official Website of SLP is: https://www.simulations-plus.com

How do I contact SLP?

SLP could be contacted at phone 661 723 7723 and can also be accessed through its website. SLP operates from 42505 Tenth Street West, Lancaster, CA 93534-7059, United States.

How many shares of SLP are traded daily?

SLP stock volume for the day was 193.66K shares. The average number of SLP shares traded daily for last 3 months was 384.98K.

What is the market cap of SLP currently?

The market value of SLP currently stands at $411.70M with its latest stock price at $20.44 and 20.15M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	243
Beta	1.09
Sales or Revenue	$79.18M
5Y Sales Change%	0.688%
Fiscal Year Ends	August
Sector	Healthcare
Industry	Medical - Healthcare Information Services

SLP Company Profile and Key Details

Simulations Plus

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Dividend & Fair Value

Valuation Metrics

Price Forecast & Outlook

Key Takeaways